MGLL and hepatocellular carcinoma: In the liver, MGL inhibition limits LPS‐induced inflammation; its global genetic and pharmacological invalidation protects against liver lesions induced by ischemia/reperfusion injury.(72) In a microarray study, the expression of MGL was found to be higher in HCC tumors than in matched tissues,(73) promoting cell growth and invasion.